All
Search
Images
Videos
Shorts
Maps
News
More
Shopping
Flights
Travel
Notebook
Report an inappropriate content
Please select one of the options below.
Not Relevant
Offensive
Adult
Child Sexual Abuse
Length
All
Short (less than 5 minutes)
Medium (5-20 minutes)
Long (more than 20 minutes)
Date
All
Past 24 hours
Past week
Past month
Past year
Resolution
All
Lower than 360p
360p or higher
480p or higher
720p or higher
1080p or higher
Source
All
Dailymotion
Vimeo
Metacafe
Hulu
VEVO
Myspace
MTV
CBS
Fox
CNN
MSN
Price
All
Free
Paid
Clear filters
SafeSearch:
Moderate
Strict
Moderate (default)
Off
Filter
Dr McCann on the Potential Clinical Utility of Gedatolisib in Advanced
…
4 months ago
onclive.com
Phase 3 VIKTORIA-2 Study: Fulvestrant & CDK4/6i /- Gedatolis
…
4 months ago
vumedi.com
Dr Han on the Investigation of Gedatolisib in HR /HER2– Metastat
…
Apr 26, 2023
onclive.com
Celcuity Inc.: Celcuity Announces First Patient Dosed in Phase 3 VIK
…
7 months ago
finanznachrichten.de
Celcuity Inc. Announces FDA Acceptance of New Drug Applicati
…
1 month ago
marketscreener.com
Celcuity Inc. Reports Clinical Data from Two Early Phase Studies of
…
8 months ago
marketscreener.com
Celcuity Inc.: Celcuity Presents Overall Survival Data from Phase
…
4 months ago
finanznachrichten.de
Le titre Celcuity s'envole après des résultats de phase 3 montrant qu
…
5 months ago
zonebourse.com
SABCS 2023 Insights: "VIKTORIA-1 Study of Gedatolisib Fulvestrant /
…
376 views
Dec 12, 2023
vumedi.com
0:15
Gedatolisib Regimens Significantly Extend Survival in Advanced Brea
…
10 views
4 months ago
YouTube
Jh Li
VIKTORIA-1 Results | Pharmacy Times
2 months ago
pharmacytimes.com
1:09
New PI3K Inhibitor Shows Promise for HER2+ Breast Cancer
10 views
1 month ago
YouTube
Oncology Perspectives
1:24
ESMO 2025: breakthrough ADC trials in TNBC and HER2+ breast c
…
950 views
5 months ago
YouTube
VJOncology
9:32
ESMO25 Breast Cancer Highlights: evERA and SERENA6 | Dana-Farb
…
277 views
4 months ago
YouTube
Dana-Farber Cancer Institute
1:07:55
PI3K/ AKT/mTOR Pathway Inhibitors in the Treatment of HR+/HER2- Me
…
3K views
5 months ago
YouTube
CancerNet Events
1:23:40
Key Steps to Success With CDK4/6 Inhibition in Early Through Metast
…
267 views
1 month ago
YouTube
PeerView Oncology
18:04
Dr. Erika Hamilton | ER+ Metastatic Breast Cancer
34 views
2 weeks ago
YouTube
OncoAlert 360
1:27
Treatment landscape post-CDK4/6 inhibitors in HR+/HER2-low metast
…
70 views
3 months ago
YouTube
VJOncology
23:34
Metastatic HR+ Breast Cancer SABCS 2025 Highlights: Dr. Hope
…
5.6K views
2 months ago
YouTube
OncBrothers: Practice-Changing Cancer Discus…
2:31
ESMO 2025 Top 10 Must See Breast Cancer Abstracts
577 views
5 months ago
YouTube
OncologyTube
1:28
ESMO 2025 Highlights: Breakthrough Data in Breast Canc
…
122 views
3 months ago
YouTube
The Oncology Brief
13:07
MECHANISM OF ACTION: DIGITALIS
11.6K views
Nov 15, 2020
YouTube
GPAT DISCUSSION CENTER
Celcuity Stock Skyrockets On Breakthrough Trial Data For Heavi
…
7 months ago
aol.co.uk
6:57
How does Dapagliflozin work? Understanding SGLT2 inhibitors.
212.5K views
Jan 31, 2019
YouTube
Zero To Finals
4:13
Sotorasib vs. Adagrasib as Treatment for KRAS G12C Mutate
…
903 views
Apr 28, 2023
YouTube
Global Resource for Advancing Cancer Education
4:52
Breast cancer highlights from ESMO 2025
3.4K views
4 months ago
YouTube
COR2ED The Heart of Medical Education
5:15
Dostarlimab- Mechanism of Action in Detail || #dostarlimab #pharmac
…
7.4K views
Jun 7, 2022
YouTube
Mindmap Factory | MBBS
22:17
Breast Cancer ESMO 2025 Highlights: MonarchE, NATALEE,
…
5.9K views
4 months ago
YouTube
OncBrothers: Practice-Changing Cancer Discus…
3:49
Navigating TROP2 ADC Options in PD-L1-Negative TNBC
1.7K views
2 months ago
YouTube
OncUpdates: Latest Oncology Insights
4:34
Trending in Oncology: ENHERTU China 2L gastric approval and more
1 views
1 month ago
YouTube
LucidQuest
See more videos
More like this
Feedback